EJNMMI Research

Article	Citations
18 F-Choline-PET/CT for non-FDG-avid salivary gland cancer: a preliminary report	50
Change in brain amyloid load and cognition in patients with amnestic mild cognitive impairment: a 3-year follow-up study	47
Influence of corticosteroid treatment on CXCR4 expression in DLBCL	34
Imaging tumor and ascites-associated macrophages in a mouse model of metastatic ovarian cancer	31
89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism	30
Adenosine-induced splenic switch-off on [15O]H2O PET perfusion for the assessment of vascular vasodilatation	29
[18F]F-FES PET for diagnosis, staging, and endocrine therapy prediction in ER-positive breast cancer: a systematic review and meta-analysis	27
Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, n	27
18F-FDG PET/CT-based deep learning radiomics predicts 5-years disease-free survival after failure to achieve pathologic complete response to neoadjuvant chemotherapy in breast cancer	26
Combatting the effect of image reconstruction settings on lymphoma [18F]FDG PET metabolic tumor volume assessment using various segmentation methods	26
Cardiometabolic disorders affect myocardial [18F]fluorodeoxyglucose uptake– impact on diagnostic PET/CT imaging	24
Biodistribution and dosimetry of the PET radioligand [18F]CHDI-650 in mice for detection of mutant huntingtin aggregates	24
18F-FAPI PET/CT imaging in pneumoconiosis: a pilot study on a novel tool for early diagnosis and guiding the treatment of pulmonary fibrosis	22
Hypometabolism and atrophy patterns associated with Niemann-Pick type C	21
Quantification of [99mTc]Tc-HDP bone SPECT/CT: can we improve the body weight based standardized uptake value with a more robust normalization?	21
Test-retest repeatability of quantitative organ and tissue uptake using 20-minute dynamic multiparametric whole-body [18F]FDG PET/CT in patients with type 2 diabetes	20
Association of white matter injury and neuroinflammation in the post-acute phase after ischemic stroke using [18F]FEPPA-PET/MRI	20
All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [177Lu]Lu-PSMA-radioligand will be successful	19
Dosimetry and preclinical evaluation of long-term radiotoxicity following treatment with 212Pb alpha-radioimmunotherapy targeting CD20	19
The value of radiomics based on 2-[18 F]FDG PET/CT in predicting WHO/ISUP grade of clear cell renal cell carcinoma	18
Establishment and validation of a clinical threshold criteria for choosing PET imaging tracers for indolent non-Hodgkin’s lymphoma	18
Drug characteristics derived from kinetic modeling: combined 11C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A	17
First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study	17
Predicting the effect of different folate doses on [68Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling	17
Radiation dosimetry and fasting-dependent hepatobiliary clearance of the VAChT-specific PET radioligand 18F-VAT in humans	17

Local staging of de novo prostate cancer using mpMRI, PSMA-PET and PSMA-PET/mpMRI – a comparative study	17
Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression	17
Preliminary mechanistic insights of a brain-penetrant microtubule imaging PET ligand in a tau-knockout mouse model	15
Quantitative renal [99mTc]DMSA imaging predicts urinary [99mTc]DMSA excretion in patients with chronic kidney disease	15
A dual-tracer approach using [11C]CH and [18F]FDG in HCC clinical decision making	14
CYP3A4 inhibitors do not influence [68Ga]Ga-DOTA-TATE uptake in liver tissue	14
Hepatobiliary PET with [68Ga]Ga-BP-IDA – preclinical evaluation and its translational potential for liver function monitoring	14
Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases	14
Autoradiographic comparison between [11C]PiB and [18F]AZD4694 in human brain tissue	14
A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points	14
Reduced splenic uptake of [68Ga]Ga-Pentixafor following first-line chemotherapy is associated with poor prognosis in patients with newly diagnosed multiple myeloma	14
First-in-human use of 11C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor	13
PET imaging of GABAA receptors in pancreatic islets by [11C]flumazenil	13
Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation	13
Engineering a modular 44Ti/44Sc generator: eluate evaluation in preclinical models and estimation of human radiation dosimetry	13
Matched-pair analysis of mCRPC patients receiving 177Lu-labeled PSMA-targeted radioligand therapy in a 4-week versus 6-week treatment interval	13
TCP post-radioembolization and TCP post-EBRT in HCC are similar and can be predicted using the in vitro radiosensitivity	12
MRI ensemble model of plaque and perivascular adipose tissue as PET-equivalent for identifying carotid atherosclerotic inflammation	12
Magnetic resonance spectroscopy for enhanced multiparametric MRI characterization of [18F]FET PET-negative gliomas	12
The effects of novel macrocyclic chelates on the targeting properties of the 68Ga-labeled Gastrin releasing peptide receptor antagonist RM2	12
Ultrasensitive detection of uveal melanoma using [18F]AlF-NOTA-PRGD2 PET imaging	12
Correction: [18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism	12
Semi-quantitative indices of 2-[18F]FDG PET/CT in assessing cardiovascular and non-cardiovascular manifestations of IgG4-related disease and treatment response	12
[18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytoma	12
cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancer	11
A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides	11
Evaluation of therapeutic effect and prognostic value of 18F-FDG PET/CT in different treatment nodes of DLBCL patients	11
Quantification in respiratory-gated PET acquisition: can data-driven methods replace device-based systems?—a comparative and retrospective study	11
Effect of the identification group size and image resolution on the diagnostic performance of metabolic Alzheimer’s disease-related pattern	11
Prognostic value of 18F-FDG PET/CT-based radiomics combining dosiomics and dose volume histogram for head and neck cancer	11
Development and validation of 68Ga-PSMA-11 PET/CT-based radiomics model to detect primary prostate cancer	11
Fc-engineered monoclonal antibodies to reduce off-target liver uptake	10
Biphasic contrast-enhanced [18F]PSMA-1007 PET/CT imaging to improve the detection of local relapse of prostate cancer	10
Distinguishing lymphoma from benign lymph node diseases in fever of unknown origin using PET/CT radiomics	10
A study method using early dynamic acquisition of [18F]fluorodopa positron emission tomography for the differential diagnosis between progression and radionecrosis of brain metastases after radiothera	10
Reorganization of brain connectivity in post-COVID condition: a 18F-FDG PET study	10
Characterization of in vivo binding kinetics and non-displaceable binding of [18F]SynvesT-1 in the rat brain	10
Molecular imaging in hypertrophic cardiomyopathy: an exploratory study with 2-[18F]FDG and [13N]NH3	10
Deep learning-based radiolabelled compound-protein interaction prediction for NDUFS1-targeting radiopharmaceutical discovery	10
The effect of androgen blockade on [68Ga]Ga-PSMA-11 and [18F]FDG PET uptake in patients with recurrent or metastatic salivary duct carcinoma: a prospective imaging study	10
Imaging renal mitochondrial dysfunction in chronic kidney disease: a repurposed role for [99mTc]Tc-MIBI SPECT/CT	9
68Ga-Pentixafor PET/CT for the assessment of therapeutic outcomes following superselective adrenal arterial embolization in patients with primary aldosteronism	9
Characterisation of a novel [18F]FDG brain PET database and combination with a second database for optimising detection of focal abnormalities, using focal cortical dysplasia as an example	9
Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-centre retrospective study	9
3′-deoxy-3′-18F-fluorothymidine PET imaging of lymphoid tissues in patients with advanced non-small cell lung cancer undergoing anti-programmed cell death-1 therapy	9
Phantom and clinical evaluation of the effect of a new Bayesian penalized likelihood reconstruction algorithm (HYPER Iterative) on 68Ga-DOTA-NOC PET/CT image quality	9
Quantitative terbium-161 SPECT/CT imaging: demonstrating the feasibility of image-based dosimetry and highlighting pitfalls	9
Reduced hematopoietic-inflammatory response and worse outcomes in patients with recurrent myocardial infarction in comparison with primary myocardial infarction	9
68Ga-NOTA-RM26 PET/CT in the evaluation of glioma: a pilot prospective study	9
[18F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer’s disease pathology in APP/PS1 mice	9

Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET	9
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases	9
Molecular imaging of fibroblast activation in multiple non-ischemic cardiomyopathies	9
[18F]FDG PET-MR characterization of aortitis in the IL1rn−/− mouse model of giant-cell arteritis	9
Tumor sink effect on melanin-ligand [131I]ICF01012 in melanoma and its implications for targeted radionuclide therapy	9
Total-body 18F-FDG PET/CT: more choices to promote clinical scanning efficiency	9
Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in patients and clinically realistic simulations	9
Exploring the impact of PEGylation on pharmacokinetics: a size-dependent effect of polyethylene glycol on prostate-specific membrane antigen inhibitors	8
Imaging bone turnover assessment through volumetric density-adjusted standardized uptake value using quantitative bone SPECT/CT in osteoporosis	8
Preclinical evaluation of Affibody molecule for PET imaging of human pancreatic islets derived from stem cells	8
Predictive value of 68[Ga]Ga-DOTA-TATE PET/CT volumetric parameters in assessing treatment response to long-acting somatostatin analogues in patients with well-differentiated neuroendocrine tumours	8
Diagnostic and prognostic value of myocardial flow reserve quantification with single photon emission computed tomography – a systematic review and meta-analysis	8
Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease	8
Spatial distribution of fractionally administered holmium microspheres in non-tumorous human liver tissue: how livers survive transarterial radioembolisation	8
Evaluation of the theranostic potential of [64Cu]CuCl2 in glioblastoma spheroids	8
Blood-based transcriptomic biomarkers for response to [177Lu]Lu-DOTA-TATE therapy in neuroendocrine tumors	8
Light up heart-type fatty acid binding protein (FABP3) with a novel fluorine-18 labelled selective FABP3 ligand	8
[18F]F-FAPI-74 PET/CT for gonadal and extragonadal germ cell Tumors: a pilot study	8
Accuracy of dynamic sentinel lymph node biopsy for inguinal lymph node staging in cN0 penile cancer	8
Impact of brain segmentation methods on regional metabolism quantification in 18F-FDG PET/MR analysis	8
Chemotherapy alters radiosensitivity and GRPR expression of prostate and breast cancer cells	8
Effect of radiation therapy on lymph node fluorescence in head and neck squamous cell carcinoma after intravenous injection of indocyanine green: a prospective evaluation	8
Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study)	7
Myocardial perfusion and oxidative metabolism in healthy subjects: sex-specific insights from vasodilatory stress 11C-acetate PET	7
AI may help to predict thyroid nodule malignancy based on radiomics features from [18F]FDG PET/CT	7
99mTc-Labeled FAPI SPECT and 18F-FDG PET imaging for visualization and evaluation of connective tissue disease-associated interstitial lung disease	7
Metabolic phenotyping of hand automatisms in mesial temporal lobe epilepsy	7
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy	7
Myocardial glucose suppression may interfere with the detection of inflammatory cells with FDG-PET as suggested in a canine model of myocardial infarction	7
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer	7
Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumors	7
Feasibility of a drop-in γ-probe for radioguided sentinel lymph detection in early-stage cervical cancer	7
Effect of cerebral sinus venous thrombosis and its location on cerebral blood flow: a [15O]water PET study in acute stroke patients compared to healthy volunteers	7
Evaluation of [89Zr]Zr-girentuximab PET imaging of clear cell renal cell carcinoma in chinese patients: a Phase 1 clinical study (ZIRDOSE-CP)	7
A histogram of [18F]BBPA PET imaging differentiates non-neoplastic lesions from malignant brain tumors	7
[195mPt]Cisplatin for lung cancer imaging: a pilot study	7
Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers	7
A feasibility study of [18F] FDG PET/CT radiomics in predicting high-risk cytogenetic abnormalities in multiple myeloma	7
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): methodological application in [18F]-FDOPA PET imaging	7
External validation: a simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using PET data from DLBCL patients	7
The assessment of left ventricular volume and function in gated small animal 18F-FDG PET/CT imaging: a comparative study of three commercially available software tools	6
The intra- and interobserver variability of PSMA-expression scores in patients with primary prostate cancer	6
Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based model	6
Evaluation of [11C]UCB-A positron emission tomography in human brains	6
Model selection for dynamic PET compartmental modelling of 18F-FDG uptake using a long axial field-of-view PET scanner with delay and motion correction	6
Neuropathological correlations of 18F-florzolotau PET in a case with Pick’s disease	6
Radiation protection considerations with [89Zr]Zr-girentuximab PET and surgery	6
Clinical feasibility and impact of data-driven respiratory motion compensation studied in 200 whole-body 18F-FDG PET/CT scans	6
Radiosensitization of NET cells by HSP90 inhibitor ganetespib is mediated through pleiotropic stress responses	6
The remodeling of metabolic brain pattern in patients with extracranial diffuse large B-cell lymphoma	6
The effect of butylscopolamine on [18F]FDG uptake in the gastrointestinal tract is negligible and regionally variable	6
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma	6
Clinical significance of diffuse [18F] AlF-NOTA-FAPI-04 uptake in the thyroid on PET/CT imaging	6
Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study	6
18F-ASEM PET/MRI targeting alpha7-nicotinic acetylcholine receptor can reveal skeletal muscle denervation	6
Target occupancy study and whole-body dosimetry with a MAGL PET ligand [11C]PF-06809247 in non-human primates	6
Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18F-fluorination of boroxines, in vitro and initial in vivo evaluation	6
Brown adipose tissue machine learning nnU-Net V2 network using TriDFusion (3DF)	6
Comparative benefits of Ki and SUV images in lesion detection during PET/CT imaging	6
Kinetics of the amino acid uptake tracer O-(2-[18F]fluoroethyl)-L-tyrosine (FET) in human brain	6
Data-driven identification and semi-automated quantification of molecular targets for tumour-imaging of colorectal liver metastases and primary colorectal tumours	5
In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [177Lu]Lu-PP-F11N in humans: the lumed phase 0b study	5
Impact of non-regional lymph node metastases accurately revealed on 18F-PSMA-1007 PET/CT in the clinical management of metastatic hormone-sensitive prostate cancer	5
A preclinical study on the influence of linkers in [68Ga]Ga-NOTA-X-RM26 radiotracers for PET imaging of GRPR expression	5
PSMA-expressing, fluciclovine-negative vertebral hemangioma	5
Is CXCR4-targeted 68Ga-pentixafor PET/CT a reliable AVS-free modality for surgical decision-making and prognostic prediction in primary aldosteronism with bilateral adrenal lesions?	5
CXCR4-targeted PET imaging in rheumatoid arthritis: a novel approach for monitoring disease activity and therapeutic response	5
Clinical utility of 18F-FDG PET/CT imaging in patients with pulmonary artery sarcoma	5
Simultaneous 18F-FDG PET/MR metabolic and structural changes in visual snow syndrome and diagnostic use	5
Neuromelanin-targeted 18F-P3BZA PET/MR imaging of the substantia nigra in rhesus macaques	5
Diagnostic accuracy of cerebral [18F]FDG PET in atypical parkinsonism	5
Preoperative assessment and prognostic prediction of gastric cancer patients with peritoneal metastasis using 18F-FDG PET/CT before conversion surgery	5
Non-invasive quantification of 18F-florbetaben with total-body EXPLORER PET	5
Peptide-based PET imaging agent of tumor TIGIT expression	5
Pulmonary uptake value (PUV): a new quantification method for lung PET/CT imaging	5
Test-retest properties of [11C]PXT012253 as a positron emission tomography (PET) radiotracer in healthy human brain: PET imaging of mGlu4	5
[18F]Fluoride uptake in various bone types and soft tissues in rat	5
Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough	5
Utility of quantitative standardized uptake value from pre-operative bone SPECT/CT for predicting post-surgical MRONJ healing response	5
Predictive value of 99mTc-MAA-based dosimetry in personalized 90Y-SIRT planning for liver malignancies	5

Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients	4
Diagnostic models for fever of unknown origin based on 18F-FDG PET/CT: a prospective study in China	4
18F-FDG-PET/CT-based deep learning model for fully automated prediction of pathological grading for pancreatic ductal adenocarcinoma before surgery	4
Correction: Diagnostic and evaluative efficiency of 68Ga-FAPI-04 in skeletal muscle injury	4
Baseline 18F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma	4
Comparison of tracer kinetic models for 68Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients	4
Differentiation and correlation of regional uptake heterogeneity with cardiac dysfunction in biopsy-proven transthyretin amyloid cardiomyopathy using quantitative single-photon emission computed tomog	4
Elimination of artifacts caused by residual radiopharmaceutical activity in injection site in myocardial perfusion imaging on Discovery NM 530c semiconductor gamma camera	4
Deep learning for Parkinson’s disease classification using multimodal and multi-sequences PET/MR images	4
Improving multi-pinhole CZT myocardial perfusion imaging specificity without changing sensibility by using adapted filter parameters	4
Evaluation of a simplified radiolabeling method for a PARP inhibitor in an animal model of breast cancer	4
Diagnostic and evaluative efficiency of 68Ga-FAPI-04 in skeletal muscle injury	4
Visualizing GABA transporters in vivo: an overview of reported radioligands and future directions	4
The efficacy of short acquisition time using 18F-FDG total-body PET/CT for the identification of pediatric epileptic foci	4
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy	4
Heart ketone metabolism under acute ketone supplementation in ZDF rats, a type 2 diabetes heart failure model	4
In reply to Cheng et al. (DOI: 10.1186/s13550-023-00965-8)	4
Evaluation of damage discrimination in dopaminergic neurons using dopamine transporter PET tracer [18F]FECNT-d4	4
Automatic volumetric estimates of the left and right atrium using dynamic PET	4
A physiologically based pharmacokinetic model for [68Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients	4
Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agent	4
Lymphoscintigraphy findings in patients with chylothorax: influence of biochemical parameters	4
A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein	4
Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA	4
[68 Ga]Ga-FAPI-04 PET/CT may be a predictor for early treatment response in rheumatoid arthritis	4
The impact of patient hydration and forced diuresis on [18F]PSMA-1007 urinary bladder uptake in PET/CT imaging	4
Assessing the impact of different penalty factors of the Bayesian reconstruction algorithm Q.Clear on in vivo low count kinetic analysis of [11C]PHNO brain PET-MR studies	3
Prognostic value of molecular and radiologic characteristics on dedicated breast [18F]FDG PET/MRI in breast cancer patients treated with neoadjuvant chemo(targeted) therapy: a retrospective cohort stu	3
Effect of β3-adrenergic receptor agonists on [18F] fluorodeoxyglucose uptake in brown adipose tissues in positron emission tomography images of elderly patients	3
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials	3
Prospective phase II trial of [68Ga]Ga-NOTA-AE105 uPAR-PET/MRI in patients with primary gliomas: Prognostic value and Implications for uPAR-targeted Radionuclide Therapy	3
A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms	3
Physiological provocation compared to acetazolamide in the assessment of cerebral hemodynamics: a case report	3
Discrimination of benign, atypical, and malignant peripheral nerve sheath tumours in neurofibromatosis type 1 – intraindividual comparison of positron emission computed tomography and diffusion-weight	3
Altered glucose metabolism in default mode network and prefrontal circuit in patients with Kallmann syndrome	3
Normal values for 18F-FDG uptake in organs and tissues measured by dynamic whole body multiparametric FDG PET in 126 patients	3
Multinomial logistic regression algorithm for the classification of patients with parkinsonisms	3
Non-invasive arterial input function estimation using an MRA atlas and machine learning	3
Preclinical evaluation and first-in-human study of [18F]AlF-FAP-NUR for PET imaging cancer-associated fibroblasts	3
Preclinical biodistribution and dosimetry and human biodistribution comparing 18F-rhPSMA-7 and single isomer 18F-rhPSMA-7.3	3
Influence of fasting prior to 18F-rhPSMA-7.3 (Flotufolastat F-18) PET/CT on biodistribution and tumor uptake	3
ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors	3
In vivo vesicular acetylcholine transporter density in human peripheral organs: an [18F]FEOBV PET/CT study	3
P2X 7-receptor binding in new-onset and secondary progressive MS – a [11C]SMW139 PET study	3
PSMA imaging as a non-invasive tool to monitor inducible gene expression in vivo	3
[68Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism	3
In silico analysis of radiation-induced double-strand breaks by internal ex vivo irradiation of lymphocytes for 45 alpha- and beta/gamma-emitting radionuclides	3
Relaxed fibronectin: a potential novel target for imaging endometriotic lesions	3
Quantitative evaluation of thyroid bed accumulation in I-131 radiotherapy: a comparison of laryngeal edema and non-edematous cases	3
Biomarkers of bone metabolism in [223Ra] RaCl2 therapy - association with extent of disease and prediction of overall survival	3
Tolerability of PSMA radioligand therapy in metastatic prostate cancer patients with baseline mild to moderate leukopenia	3
New improved radiometabolite analysis method for [18F]FTHA from human plasma: a test-retest study with postprandial and fasting state	3
Measurement of specific and nonspecific tissue uptake of antibodies in tumor by SPECT imaging and nonlinear compartmental modeling	3
Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging study	3
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology	3
Use of relative Patlak plot Ki′ images as an alternative to standard Patlak plot Ki images in clinical practice	3
Effects of isoflurane anaesthesia depth and duration on renal function measured with [99mTc]Tc-mercaptoacetyltriglycine SPECT in mice	3
In vitro and ex vivo evaluation of preclinical models for FAP-targeted theranostics: differences and relevance for radiotracer evaluation	2
Machine learning for prognostic prediction in coronary artery disease with SPECT data: a systematic review and meta-analysis	2
Automated extraction of the arterial input function from brain images for parametric PET studies	2
Predicting pathological response to neoadjuvant chemoradiotherapy in resectable and borderline resectable pancreatic ductal adenocarcinoma: a comparative study of 18F-FLT and 18F-FDG PET	2
The impact of introducing deep learning based [18F]FDG PET denoising on EORTC and PERCIST therapeutic response assessments in digital PET/CT	2
Correction: The association of DAT gene methylation with striatal DAT availability in healthy subjects	2
Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment	2
Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC	2
Correction: Quantification of [99mTc]Tc-HDP bone SPECT/CT: can we improve the body weight based standardized uptake value with a more robust normalization?	2
Comparing three methodologies for network analysis of human [11C]glyburide whole-body PET data: d-networks, s-networks, and ΔPCC networks	2
Early diagnosis and staging of paraquat-induced pulmonary fibrosis using [18F]F-FAPI-42 PET/CT imaging	2
Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancer	2
Radiosynthesis automation, non-human primate biodistribution and dosimetry of K+ channel tracer [11C]3MeO4AP	2
Comparison of [18F]-FDOPA PET and [123I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome	2
Cardiac sympathetic activity and lethal arrhythmic events: insight into bell-shaped relationship between 123I-meta-iodobenzylguanidine activity and event rates	2
Evaluation of INR101, a PSMA-Targeted 18F PET Tracer, for suspected prostate cancer: A multicenter phase I/IIa trial with histopathologic confirmation	2
Pilot study of humanized glypican-3-targeted zirconium-89 immuno-positron emission tomography for hepatocellular carcinoma	2
An update on the use of image-derived input functions for human PET studies: new hopes or old illusions?	2
Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET	2
Increased lesion detectability in patients with locally advanced breast cancer—A pilot study using dynamic whole-body [18F]FDG PET/CT	2
CMR validation of left ventricular volumes and ejection fraction measured by the IQ-SPECT system in patients with small heart size	2
Primary mesenchymal tumors of the prostate:18F FDG PET/CT findings	2
Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET/CT in patients with low β-hydroxybutyrate level	2
The image quality and feasibility of solitary delayed [68 Ga]Ga-PSMA-11 PET/CT using long field-of-view scanning in patients with prostate cancer	2
The potential application of MR-derived ADCmin values from 68Ga-DOTATATE and 18F-FDG dual tracer PET/MR as replacements for FDG PET in assessment of grade and stage of pancreatic neuroendocrine tumors	2
Brain 18 F-FDG PET reveals cortico-subcortical hypermetabolic dysfunction in juvenile neuropsychiatric systemic lupus erythematosus	2
The predictive value of [18F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma	2
Staging lung cancer: total-body PET/CT or whole-body PET/CT?	2
SPECT/CT in addition to subtraction parathyroid scintigraphy in hyperparathyroidism: diagnostic performance in a cohort of predominantly end-stage renal disease patients	2
CXCR4 peptide-based fluorescence endoscopy in a mouse model of Barrett’s esophagus	2
Unravelling physical and radiobiological effects of proton boron fusion reaction with anionic metallacarboranes ([o-COSAN]-) in breast cancer cells	2
Evaluation of folate receptor-alpha and other surface markers as potential targets for radionuclide therapy of ovarian cancer	2
Allometry correction in semi-quantitative analysis of dopamine transporter SPECT	2
Radiomics predictive modeling from dual-time-point FDG PET Ki parametric maps: application to chemotherapy response in lymphoma	2
Larger 18F-fluoroboronotyrosine (FBY) active volume beyond MRI contrast enhancement in diffuse gliomas than in circumscribed brain tumors	2
Targeted imaging of very late antigen-4 for noninvasive assessment of lung inflammation-fibrosis axis	2
Evaluation of gastrin-releasing peptide receptor, prostate-specific membrane antigen, and neurotensin receptor 1 as potential biomarkers for accurate prostate cancer stratified diagnosis	2
3D-printed dual holder system for simultaneous rat PET scanning: design and influence on quantification	2